The Lancet Infectious Diseases
@thelancetinfdis.bsky.social
The Lancet Infectious Diseases is the leading clinical infectious diseases journal for peer-reviewed research and review, comment, and news.
🌐 https://www.thelancet.com/journals/laninf/home
🌐 https://www.thelancet.com/journals/laninf/home
Read our December issue!
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
November 20, 2025 at 5:51 AM
Read our December issue!
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
📅 Marco De Ambrogi will be attending ASTMH 2025, #TropMed25, November 9-13, 2025 in Toronto, Ontario, Canada on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
November 4, 2025 at 3:50 PM
📅 Marco De Ambrogi will be attending ASTMH 2025, #TropMed25, November 9-13, 2025 in Toronto, Ontario, Canada on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
Read our November issue!
Featuring testing olorofim to treat fungal infections, introduction of nirsevimab for RSV in Chile, and new oxazolidinones for tuberculosis therapy.
www.thelancet.com/issue/S1473-...
Featuring testing olorofim to treat fungal infections, introduction of nirsevimab for RSV in Chile, and new oxazolidinones for tuberculosis therapy.
www.thelancet.com/issue/S1473-...
October 23, 2025 at 8:55 AM
Read our November issue!
Featuring testing olorofim to treat fungal infections, introduction of nirsevimab for RSV in Chile, and new oxazolidinones for tuberculosis therapy.
www.thelancet.com/issue/S1473-...
Featuring testing olorofim to treat fungal infections, introduction of nirsevimab for RSV in Chile, and new oxazolidinones for tuberculosis therapy.
www.thelancet.com/issue/S1473-...
📅 @phoebedownes.bsky.social will be attending ID Week, #IDWeek (19-22 October) in Atlanta, GA on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
October 13, 2025 at 11:26 AM
📅 @phoebedownes.bsky.social will be attending ID Week, #IDWeek (19-22 October) in Atlanta, GA on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
Read our October issue!
Featuring a trial testing moxidectin for lymphatic filariasis, bedaquiline resistance and tuberculosis outcomes, and a recombinant influenza vaccine for children.
www.thelancet.com/issue/S1473-...
Featuring a trial testing moxidectin for lymphatic filariasis, bedaquiline resistance and tuberculosis outcomes, and a recombinant influenza vaccine for children.
www.thelancet.com/issue/S1473-...
September 25, 2025 at 1:22 PM
Read our October issue!
Featuring a trial testing moxidectin for lymphatic filariasis, bedaquiline resistance and tuberculosis outcomes, and a recombinant influenza vaccine for children.
www.thelancet.com/issue/S1473-...
Featuring a trial testing moxidectin for lymphatic filariasis, bedaquiline resistance and tuberculosis outcomes, and a recombinant influenza vaccine for children.
www.thelancet.com/issue/S1473-...
🗓️ Saleha Hassan will be attending the Global AMR Innovators Conference, #GAMRIC2025 (1-3 October) in London on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
September 24, 2025 at 12:27 PM
🗓️ Saleha Hassan will be attending the Global AMR Innovators Conference, #GAMRIC2025 (1-3 October) in London on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
🗓️ Claire Lenahan will be attending the 6th ESCMID Conference on #Vaccines 2025 (10th-13th September) in Lisbon on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
September 3, 2025 at 1:27 PM
🗓️ Claire Lenahan will be attending the 6th ESCMID Conference on #Vaccines 2025 (10th-13th September) in Lisbon on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
Read our September issue!
Featuring an investigation on the spread of Oropouche virus, an updation of the WHO Bacterial Pathogen List, and whether there is a benefit of RSV vaccination in pregnancy.
www.thelancet.com/issue/S1473-...
Featuring an investigation on the spread of Oropouche virus, an updation of the WHO Bacterial Pathogen List, and whether there is a benefit of RSV vaccination in pregnancy.
www.thelancet.com/issue/S1473-...
August 21, 2025 at 10:53 AM
Read our September issue!
Featuring an investigation on the spread of Oropouche virus, an updation of the WHO Bacterial Pathogen List, and whether there is a benefit of RSV vaccination in pregnancy.
www.thelancet.com/issue/S1473-...
Featuring an investigation on the spread of Oropouche virus, an updation of the WHO Bacterial Pathogen List, and whether there is a benefit of RSV vaccination in pregnancy.
www.thelancet.com/issue/S1473-...
Read our August issue!
Featuring pertussis vaccination in pregnancy in Gambian women, whether STIs can be prevented using doxycycline post-exposure, and definition of the primaquine dose to treat P. vivax malaria.
www.thelancet.com/issue/S1473-...
Featuring pertussis vaccination in pregnancy in Gambian women, whether STIs can be prevented using doxycycline post-exposure, and definition of the primaquine dose to treat P. vivax malaria.
www.thelancet.com/issue/S1473-...
July 24, 2025 at 7:51 AM
Read our August issue!
Featuring pertussis vaccination in pregnancy in Gambian women, whether STIs can be prevented using doxycycline post-exposure, and definition of the primaquine dose to treat P. vivax malaria.
www.thelancet.com/issue/S1473-...
Featuring pertussis vaccination in pregnancy in Gambian women, whether STIs can be prevented using doxycycline post-exposure, and definition of the primaquine dose to treat P. vivax malaria.
www.thelancet.com/issue/S1473-...
Are you ready for your research to spark global conversation? ✨ Begin your publication journey with us today and help to advance health and science worldwide. hubs.li/Q03vpxN70
July 4, 2025 at 7:47 AM
Are you ready for your research to spark global conversation? ✨ Begin your publication journey with us today and help to advance health and science worldwide. hubs.li/Q03vpxN70
Congratulations to our authors and peer reviewers, whose expertise and hard work enable us to continuously publish the best science for better lives. This is as much your achievement!
July 4, 2025 at 7:47 AM
Congratulations to our authors and peer reviewers, whose expertise and hard work enable us to continuously publish the best science for better lives. This is as much your achievement!
Read our July issue!
Featuring malaria prevention with sulfadoxine-pyrimethamine in Uganda, cash transfer and counselling to promote tuberculosis treatment, sole oral treatment for Whipple’s disease, priority research agenda for Zika virus preparedness/response
www.thelancet.com/issue/S1473-...
Featuring malaria prevention with sulfadoxine-pyrimethamine in Uganda, cash transfer and counselling to promote tuberculosis treatment, sole oral treatment for Whipple’s disease, priority research agenda for Zika virus preparedness/response
www.thelancet.com/issue/S1473-...
June 19, 2025 at 2:18 PM
Read our July issue!
Featuring malaria prevention with sulfadoxine-pyrimethamine in Uganda, cash transfer and counselling to promote tuberculosis treatment, sole oral treatment for Whipple’s disease, priority research agenda for Zika virus preparedness/response
www.thelancet.com/issue/S1473-...
Featuring malaria prevention with sulfadoxine-pyrimethamine in Uganda, cash transfer and counselling to promote tuberculosis treatment, sole oral treatment for Whipple’s disease, priority research agenda for Zika virus preparedness/response
www.thelancet.com/issue/S1473-...
Read our June issue!
Featuring effectiveness of RSV vaccination in older people in the US, malaria prevention in children with sickle-cell anaemia, and testing new serological tools for arboviral infections
www.thelancet.com/journals/lan...
Featuring effectiveness of RSV vaccination in older people in the US, malaria prevention in children with sickle-cell anaemia, and testing new serological tools for arboviral infections
www.thelancet.com/journals/lan...
May 22, 2025 at 11:33 AM
Read our June issue!
Featuring effectiveness of RSV vaccination in older people in the US, malaria prevention in children with sickle-cell anaemia, and testing new serological tools for arboviral infections
www.thelancet.com/journals/lan...
Featuring effectiveness of RSV vaccination in older people in the US, malaria prevention in children with sickle-cell anaemia, and testing new serological tools for arboviral infections
www.thelancet.com/journals/lan...
Read our May issue!
Featuring the global burden of diarrhoeal diseases, Hepatitis E vaccination to control an outbreak in South Sudan, and antimicrobial therapy for Pseudomonas aeruginosa
www.thelancet.com/journals/lan...
Featuring the global burden of diarrhoeal diseases, Hepatitis E vaccination to control an outbreak in South Sudan, and antimicrobial therapy for Pseudomonas aeruginosa
www.thelancet.com/journals/lan...
April 24, 2025 at 10:00 AM
Read our May issue!
Featuring the global burden of diarrhoeal diseases, Hepatitis E vaccination to control an outbreak in South Sudan, and antimicrobial therapy for Pseudomonas aeruginosa
www.thelancet.com/journals/lan...
Featuring the global burden of diarrhoeal diseases, Hepatitis E vaccination to control an outbreak in South Sudan, and antimicrobial therapy for Pseudomonas aeruginosa
www.thelancet.com/journals/lan...
Still unsure which session to attend this afternoon at #ESCMIDGlobal?
Come to the late breakers from The Lancet group at 16:15 in Hall 16!
Come to the late breakers from The Lancet group at 16:15 in Hall 16!
April 14, 2025 at 10:40 AM
Still unsure which session to attend this afternoon at #ESCMIDGlobal?
Come to the late breakers from The Lancet group at 16:15 in Hall 16!
Come to the late breakers from The Lancet group at 16:15 in Hall 16!
Read our April issue!
Featuring drivers of Oropouche virus in Brazil, a new TB drug, and Yeo virus infection in China
www.thelancet.com/journals/lan...
Featuring drivers of Oropouche virus in Brazil, a new TB drug, and Yeo virus infection in China
www.thelancet.com/journals/lan...
March 27, 2025 at 6:38 AM
Read our April issue!
Featuring drivers of Oropouche virus in Brazil, a new TB drug, and Yeo virus infection in China
www.thelancet.com/journals/lan...
Featuring drivers of Oropouche virus in Brazil, a new TB drug, and Yeo virus infection in China
www.thelancet.com/journals/lan...
March 7, 2025 at 10:12 AM
February 28, 2025 at 3:53 PM
The Lancet Infectious Disease's March issue is online!
Featuring SARS-CoV-2 community infections in Hong Kong, chronic pulmonary aspergillosis, and next-generation sequencing to diagnose resistant TB
www.thelancet.com/journals/lan...
Featuring SARS-CoV-2 community infections in Hong Kong, chronic pulmonary aspergillosis, and next-generation sequencing to diagnose resistant TB
www.thelancet.com/journals/lan...
February 28, 2025 at 10:05 AM
The Lancet Infectious Disease's March issue is online!
Featuring SARS-CoV-2 community infections in Hong Kong, chronic pulmonary aspergillosis, and next-generation sequencing to diagnose resistant TB
www.thelancet.com/journals/lan...
Featuring SARS-CoV-2 community infections in Hong Kong, chronic pulmonary aspergillosis, and next-generation sequencing to diagnose resistant TB
www.thelancet.com/journals/lan...